Top Abstract Purchase Related
Home
>
Node
>
Subnode

The protective action of fluocortin butylester (FCB) in the nasal antigen provocation test: a controlled double-blind, crossover study

Horak, F.; Matthes, H.

Annals of Allergy 48(5): 305-308

1982

ISSN/ISBN: 0003-4738
PMID: 7044195
Document Number: 190072
Fluocortin butylester (FCB), a locally active corticosteroid, was inhaled as a fine powder mixed with lactose using the rhinolator in a comparative double-blind, crossover study against placebo. Fifty patients of both sexes and aged from 16 to 46 years with an established seasonal allergic rhinitis, but free of symptoms, took part in this trial. The determination of the protective action after allergen provocation was performed after seven days treatment with 4 mg FCB or placebo. Measurements of the nasal resistance and the temperature were taken after provocation. The symptoms of nose and eyes were recorded. The protective effect of FCB against nasal provocation with grass pollen extracts was statistically proved.

Document emailed within 1 workday
Secure & encrypted payments

Franke, W.; Bachert, C.; Messinger, D. 1989: Double-blind controlled crossover study comparing the protective effect of picumast dihydrochloride versus placebo following nasal allergen challenge Arzneimittel-Forschung 39(10a): 1354-1356
Dave, N.K.; McMahon, S.C.; Grubbe, R.E.; Bewtra, A.K.; Hopp, R.J.; Nair, N.M.; Smith, J.; Townley, R.G. 1990: A controlled, double-blind study of the effect of quazolast on nasal challenge with ragweed antigen Annals of Allergy 65(4): 298-302
Brügmann, U.; Blasini, R.; Rudolph, W. 1983: Anti-ischemic effect of nifedipine in delayed-action form. Results of a double-blind, randomized, crossover, placebo-controlled acute study Herz 8(4): 206-210
De Buck, R.; Van Durme, R.; Pelc, I. 1975: A controlled double-blind crossover study of the efficacy of mepiprazol (EMD 16.923) and of diazepam in the treatment of neurotic disorders Acta Psychiatrica Belgica 75(3): 320-333
Karniol, I.G.; Portela, W. 1982: Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study Brazilian Journal of Medical and Biological Research 15(6): 389-394
Voigt, U.; Klassen, E. 1982: Testing of ketoprofen for interaction with oral antidiabetics. a double-blind controlled clinical crossover study Die Medizinische Welt 33(45): 1592-1593
Langrick, A.F.; Gunn, A.D.; Livesey, H.; Whitehead, A.M. 1989: A double-blind placebo-controlled crossover study of mebeverine and mefenamic acid in the treatment of primary dysmenorrhoea British Journal of Clinical Practice 43(9): 317-321
Moldofsky, H.; Lue, F.A.; Mously, C.; Roth-Schechter, B.; Reynolds, W.J. 1996: The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study Journal of Rheumatology 23(3): 529-533
Gulias-Herrero, A.; Aguilar-Salinas, C.A.; Gómez-Pérez, F.J.; Rull, J.A. 2003: The combination metformin/glyburide exerts its hypoglycemic effect mainly by increasing insulin secretion: a controlled, randomized, double-blind, crossover study Diabetes Nutrition and Metabolism 16(5-6): 268-276
Fauvel, J.P.; Najem, R.; Maakel, N.; Pozet, N.; Laville, M. 1998: Effects of moxonidine on stress-induced peak blood pressure and renal function: a randomized, double-blind, placebo-controlled crossover study Journal of Cardiovascular Pharmacology 32(3): 495-499
Bozza, A.E.; Guimarães, F.J.; de Carvalho, F.J.; Santos, L.C.; Pellon, F.M.; de Castro, R.F.; Balbuena, R.R. 1984: Comparative double-blind, randomized, crossover study controlled with placebo, of the efficacy of depot nifedipine in patients refractory to basic antihypertensive therapy Arquivos Brasileiros de Cardiologia 43(3): 213-217
Dougados, M.; Caporal, R.; Doury, P.; Thiesce, A.; Pattin, S.; Laffez, B.; Amor, B. 1989: A double blind crossover placebo controlled trial of ximoprofen in as Journal of Rheumatology 16(8): 1167-1169
Clerico, M.; Bertetto, O.; Morandini, M.P.; Cardinali, C.; Giaccone, G. 1993: Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design Tumori 79(2): 119-122
Simon, B.; Koch, E.M.; Jackisch, P.; Müller, P. 1993: Circadian dependency of ibuprofen gastropathy and the protective effect of ranitidine. An endoscopic, controlled double-blind pilot study Arzneimittel-Forschung 43(9): 989-991
Gex-Collet, C.; Imhof, L.; Brattström, A.; Pichler, W.J.; Helbling, A. 2006: The butterbur extract petasin has no effect on skin test reactivity induced by different stimuli: a randomized, double-blind crossover study using histamine, codeine, methacholine, and aeroallergen solutions Journal of Investigational Allergology and Clinical Immunology 16(3): 156-161
Goldzieher, J.W.; Moses, L.E.; Averkin, E.; Scheel, C.; Taber, B.Z. 1971: A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives Fertility and Sterility 22(9): 609-623
Pozzi, E.; Rossi, A.; Frigerio, G. 1973: Controlled double blind study on the action of phentonium in comparison with aminophylline in bronchial spasms Minerva Medica 64(71): 3705-3708
Soonthornpun, S.; Rattarasarn, C.; Thamprasit, A.; Leetanaporn, K. 1998: Effect of acarbose in treatment of type Ii diabetes mellitus: a double-blind, crossover, placebo-controlled trial Journal of the Medical Association of Thailand 81(3): 195-200
Castellano, F.; Mautone, G. 2002: Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study Drugs under Experimental and Clinical Research 28(1): 27-35
Young, S.A.; Hurt, P.H.; Benedek, D.M.; Howard, R.S. 1998: Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial Journal of Clinical Psychiatry 59(2): 76-80